Report Detail
Global Inhaled Asthma Medications Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4662710 |
- 31 December, 2025 |
- Global |
- 104 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Inhaled Asthma Medications market size was valued at US$ 18180 million in 2024 and is forecast to a readjusted size of USD 25950 million by 2031 with a CAGR of 5.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Inhaled asthma medications are a cornerstone of asthma management, delivering medication directly to the lungs for rapid and effective relief of symptoms. These medications include bronchodilators, such as short-acting beta-agonists (e.g., albuterol) for quick relief during asthma attacks, and long-acting beta-agonists (e.g., salmeterol) for ongoing control. Inhaled corticosteroids (e.g., fluticasone) are commonly used for long-term management to reduce inflammation and prevent exacerbations. Combination inhalers that include both a corticosteroid and a long-acting bronchodilator are also available for more comprehensive control. The inhalation route ensures high local drug concentration with minimal systemic side effects, enhancing efficacy and safety. Proper inhaler technique and adherence to prescribed treatment regimens are essential for optimal asthma control, reducing the frequency and severity of asthma symptoms, and improving overall quality of life for patients.
This report is a detailed and comprehensive analysis for global Inhaled Asthma Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Inhaled Asthma Medications market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Inhaled Asthma Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Inhaled Asthma Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Inhaled Asthma Medications market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inhaled Asthma Medications
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inhaled Asthma Medications market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceutical, GSK, Merck, Roche, AstraZeneca, Boehringer Ingelheim International, Sanofi, BD, Covis Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Inhaled Asthma Medications market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Dry Powder
Soft Mist
Market segment by Application
Anti-inflammatory
Bronchodilators
Combination Therapy
Other
Major players covered
Teva Pharmaceutical
GSK
Merck
Roche
AstraZeneca
Boehringer Ingelheim International
Sanofi
BD
Covis Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inhaled Asthma Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inhaled Asthma Medications, with price, sales quantity, revenue, and global market share of Inhaled Asthma Medications from 2020 to 2025.
Chapter 3, the Inhaled Asthma Medications competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhaled Asthma Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Inhaled Asthma Medications market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inhaled Asthma Medications.
Chapter 14 and 15, to describe Inhaled Asthma Medications sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Inhaled Asthma Medications Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Dry Powder
- 1.3.3 Soft Mist
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Inhaled Asthma Medications Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Anti-inflammatory
- 1.4.3 Bronchodilators
- 1.4.4 Combination Therapy
- 1.4.5 Other
- 1.5 Global Inhaled Asthma Medications Market Size & Forecast
- 1.5.1 Global Inhaled Asthma Medications Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Inhaled Asthma Medications Sales Quantity (2020-2031)
- 1.5.3 Global Inhaled Asthma Medications Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Teva Pharmaceutical
- 2.1.1 Teva Pharmaceutical Details
- 2.1.2 Teva Pharmaceutical Major Business
- 2.1.3 Teva Pharmaceutical Inhaled Asthma Medications Product and Services
- 2.1.4 Teva Pharmaceutical Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Teva Pharmaceutical Recent Developments/Updates
- 2.2 GSK
- 2.2.1 GSK Details
- 2.2.2 GSK Major Business
- 2.2.3 GSK Inhaled Asthma Medications Product and Services
- 2.2.4 GSK Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 GSK Recent Developments/Updates
- 2.3 Merck
- 2.3.1 Merck Details
- 2.3.2 Merck Major Business
- 2.3.3 Merck Inhaled Asthma Medications Product and Services
- 2.3.4 Merck Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Merck Recent Developments/Updates
- 2.4 Roche
- 2.4.1 Roche Details
- 2.4.2 Roche Major Business
- 2.4.3 Roche Inhaled Asthma Medications Product and Services
- 2.4.4 Roche Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Roche Recent Developments/Updates
- 2.5 AstraZeneca
- 2.5.1 AstraZeneca Details
- 2.5.2 AstraZeneca Major Business
- 2.5.3 AstraZeneca Inhaled Asthma Medications Product and Services
- 2.5.4 AstraZeneca Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 AstraZeneca Recent Developments/Updates
- 2.6 Boehringer Ingelheim International
- 2.6.1 Boehringer Ingelheim International Details
- 2.6.2 Boehringer Ingelheim International Major Business
- 2.6.3 Boehringer Ingelheim International Inhaled Asthma Medications Product and Services
- 2.6.4 Boehringer Ingelheim International Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Boehringer Ingelheim International Recent Developments/Updates
- 2.7 Sanofi
- 2.7.1 Sanofi Details
- 2.7.2 Sanofi Major Business
- 2.7.3 Sanofi Inhaled Asthma Medications Product and Services
- 2.7.4 Sanofi Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Sanofi Recent Developments/Updates
- 2.8 BD
- 2.8.1 BD Details
- 2.8.2 BD Major Business
- 2.8.3 BD Inhaled Asthma Medications Product and Services
- 2.8.4 BD Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 BD Recent Developments/Updates
- 2.9 Covis Pharma
- 2.9.1 Covis Pharma Details
- 2.9.2 Covis Pharma Major Business
- 2.9.3 Covis Pharma Inhaled Asthma Medications Product and Services
- 2.9.4 Covis Pharma Inhaled Asthma Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Covis Pharma Recent Developments/Updates
3 Competitive Environment: Inhaled Asthma Medications by Manufacturer
- 3.1 Global Inhaled Asthma Medications Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Inhaled Asthma Medications Revenue by Manufacturer (2020-2025)
- 3.3 Global Inhaled Asthma Medications Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Inhaled Asthma Medications by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Inhaled Asthma Medications Manufacturer Market Share in 2024
- 3.4.3 Top 6 Inhaled Asthma Medications Manufacturer Market Share in 2024
- 3.5 Inhaled Asthma Medications Market: Overall Company Footprint Analysis
- 3.5.1 Inhaled Asthma Medications Market: Region Footprint
- 3.5.2 Inhaled Asthma Medications Market: Company Product Type Footprint
- 3.5.3 Inhaled Asthma Medications Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Inhaled Asthma Medications Market Size by Region
- 4.1.1 Global Inhaled Asthma Medications Sales Quantity by Region (2020-2031)
- 4.1.2 Global Inhaled Asthma Medications Consumption Value by Region (2020-2031)
- 4.1.3 Global Inhaled Asthma Medications Average Price by Region (2020-2031)
- 4.2 North America Inhaled Asthma Medications Consumption Value (2020-2031)
- 4.3 Europe Inhaled Asthma Medications Consumption Value (2020-2031)
- 4.4 Asia-Pacific Inhaled Asthma Medications Consumption Value (2020-2031)
- 4.5 South America Inhaled Asthma Medications Consumption Value (2020-2031)
- 4.6 Middle East & Africa Inhaled Asthma Medications Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Inhaled Asthma Medications Sales Quantity by Type (2020-2031)
- 5.2 Global Inhaled Asthma Medications Consumption Value by Type (2020-2031)
- 5.3 Global Inhaled Asthma Medications Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Inhaled Asthma Medications Sales Quantity by Application (2020-2031)
- 6.2 Global Inhaled Asthma Medications Consumption Value by Application (2020-2031)
- 6.3 Global Inhaled Asthma Medications Average Price by Application (2020-2031)
7 North America
- 7.1 North America Inhaled Asthma Medications Sales Quantity by Type (2020-2031)
- 7.2 North America Inhaled Asthma Medications Sales Quantity by Application (2020-2031)
- 7.3 North America Inhaled Asthma Medications Market Size by Country
- 7.3.1 North America Inhaled Asthma Medications Sales Quantity by Country (2020-2031)
- 7.3.2 North America Inhaled Asthma Medications Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Inhaled Asthma Medications Sales Quantity by Type (2020-2031)
- 8.2 Europe Inhaled Asthma Medications Sales Quantity by Application (2020-2031)
- 8.3 Europe Inhaled Asthma Medications Market Size by Country
- 8.3.1 Europe Inhaled Asthma Medications Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Inhaled Asthma Medications Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Inhaled Asthma Medications Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Inhaled Asthma Medications Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Inhaled Asthma Medications Market Size by Region
- 9.3.1 Asia-Pacific Inhaled Asthma Medications Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Inhaled Asthma Medications Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Inhaled Asthma Medications Sales Quantity by Type (2020-2031)
- 10.2 South America Inhaled Asthma Medications Sales Quantity by Application (2020-2031)
- 10.3 South America Inhaled Asthma Medications Market Size by Country
- 10.3.1 South America Inhaled Asthma Medications Sales Quantity by Country (2020-2031)
- 10.3.2 South America Inhaled Asthma Medications Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Inhaled Asthma Medications Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Inhaled Asthma Medications Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Inhaled Asthma Medications Market Size by Country
- 11.3.1 Middle East & Africa Inhaled Asthma Medications Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Inhaled Asthma Medications Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Inhaled Asthma Medications Market Drivers
- 12.2 Inhaled Asthma Medications Market Restraints
- 12.3 Inhaled Asthma Medications Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Inhaled Asthma Medications and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Inhaled Asthma Medications
- 13.3 Inhaled Asthma Medications Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Inhaled Asthma Medications Typical Distributors
- 14.3 Inhaled Asthma Medications Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Inhaled Asthma Medications. Industry analysis & Market Report on Inhaled Asthma Medications is a syndicated market report, published as Global Inhaled Asthma Medications Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Inhaled Asthma Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
